IGM Biosciences announced the discontinuation of imvotamab and IGM-2644 for autoimmune and inflammatory diseases, including ...

Practice of medicine could fundamentally change with these types of therapies,” said CEO Jaideep Dudani, of T cell engagers ...

Scientists in New Zealand blame waning antibody levels. Antibody responses in 150 regular blood donors were measured across the pandemic’s first three years for immunity against a range of ...

The anti-TL1A antibody allowed significantly more inflammatory bowel disease (IBD) patients to go into remission than those taking placebo treatment. Teva announced it was partnering with Sanofi to ...

making antibodies a critical defense against disease in our immune arsenal. This story is from the WIRED World in 2025, our annual trends briefing. This precise targeting ability also means they ...

A previously unknown disease making the rounds in the Democratic Republic of Congo (DRC) is a severe form of malaria, the country’s health ministry has announced. Health authorities on Tuesday ...

Scientists in New Zealand blame waning antibody levels. Antibody responses in 150 regular blood donors were measured across the pandemic’s first three years for immunity against a range of pathogens ...

GBS, Guillain-Barre Syndrome; CIDP, chronic inflammatory demyelinating polyneuropathy; NMOSD, neuromyelitis optica spectrum disorders; MOGAD, myelin oligodendrocyte glycoprotein antibody-associated ...

This unsettling event has reignited discussions about “Disease X.” Disease X is not an actual but a hypothetical disease. The World Health Organization (WHO) coined the term in 2018 to ...

Early diagnosis Instrumental and laboratory investigations, signs and symptoms SSc RP, puffy fingers, ANA (anticentromere antibodies and ... Interstitial lung disease; NT-proBNP: N-terminal ...